<DOC>
	<DOCNO>NCT02095769</DOCNO>
	<brief_summary>The goal POETRY Registry determine whether data Pharmacogenomic ( PGx ) Testing elderly disabled patient help physician manage patient medication regimens assess test effect reduce adverse drug event , hospitalization , emergency department visit . The way individual process metabolizes drug part determine gene , know genetic variation one human another . The study way gene affect individual 's response drug know `` Pharmacogenomics . ''</brief_summary>
	<brief_title>Pharmacogenomic Testing Of Elderly To Reduce Morbidity</brief_title>
	<detailed_description />
	<criteria>Subject underwent PGx test allele appropriate target drug within prior 90 day ( 'index PGx test ' ) Males female age ≥65 year male female age ≥18 year disability Subject able willing provide write informed consent Subject receive least one medication know associate allelic variation time index PGx test , include overthecounter medication Subject history least one target drugrelated adverse event ( TDAE ) 12month period precede receipt PGx test result , experienced inadequate efficacy target drug Subject currently hospitalize Subject 's medical medication history unavailable 90day period precede receipt PGx test result Subject unable provide accurate history due mental incapacity Subject know undergone prior PGx test gene specific target drug ( ) , exclusive PGx test relating Registry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Pharmacogenomics</keyword>
	<keyword>Adverse Drug Reactions</keyword>
</DOC>